Can Aging in Place Be Cost Effective? A Systematic Review by Graybill EM et al.
 Newcastle University ePrints 
 
Graybill EM, McMeekin P, Wildman J. Can Aging in Place Be Cost Effective? A 
Systematic Review. PLoS One 2014, 9(7), e102705. 
Copyright: 
©2014 Graybill et al. This is an open-access article distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original author and source are credited.  
DOI link to article: 
http://dx.doi.org/10.1371/journal.pone.0102705 
Date deposited:   04-09-2014 
 
 
 
 
This work is licensed under a Creative Commons Attribution 3.0 Unported License 
 
 ePrints – Newcastle University ePrints 
http://eprint.ncl.ac.uk 
 
Can Aging in Place Be Cost Effective? A Systematic
Review
Erin M. Graybill1*, Peter McMeekin1, John Wildman2
1 Institute of Health & Society, Newcastle University, Newcastle upon Tyne, United Kingdom, 2 Business School, Newcastle University, Newcastle upon Tyne, United
Kingdom
Abstract
Purpose of the Study: To systematically review cost, cost-minimization and cost-effectiveness studies for assisted living
technologies (ALTs) that specifically enable older people to ‘age in place’ and highlight what further research is needed to
inform decisions regarding aging in place.
Design: People aged 65+ and their live-in carers (where applicable), using an ALT to age in place at home opposed to a
community-dwelling arrangement.
Methods: Studies were identified using a predefined search strategy on two key economic and cost evaluation databases
NHS EED, HEED. Studies were assessed using methods recommended by the Campbell and Cochrane Economic Methods
Group and presented in a narrative synthesis style.
Results: Eight eligible studies were identified from North America spread over a diverse geographical range. The majority of
studies reported the ALT intervention group as having lower resource use costs than the control group; though the low
methodological quality and heterogeneity of the individual costs and outcomes reported across studies must be
considered.
Implications: The studies suggest that in some cases ALTs may reduce costs, though little data were identified and what
there were was of poor quality. Methods to capture quality of life gains were not used, therefore potential effects on health
and wellbeing may be missed. Further research is required using newer developments such as the capabilities approach.
High quality studies assessing the cost-effectiveness of ALTs for ageing in place are required before robust conclusion on
their use can be drawn.
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Introduction
Many adults want to grow old in their own homes (age in place)
as opposed to a community living arrangement [1] [2], but there
are challenges to independent living for healthy older adults as well
as those who are unwell [3]. Aging populations require innovative
solutions to the problems of maintaining independence, dignity
and home care, and assisted living technologies (ALTs) may play a
key role. ALTs can theoretically facilitate older people (those aged
age 65+ [4]) aging in place and can be categorized into two
groups. Firstly, Home and Environmental Modifications, which
are technologies or modifications that can be installed or used
within a home to promote independent living, usually by
increasing mobility (e.g. ramp, adapted kitchen tools), or
mediating risk of injury (e.g. grab rails in bath, wheelchair lift on
stairs). Secondly, Telemedicine which includes any technology that
provides remote communication between people in their home
and healthcare or security professionals [5,6] (e.g. home surveil-
lance technology to monitor the condition of the older person by
transmitting routine physiological data).
Although technological advancements continue to evolve, the
healthcare industry has been hesitant to adapt [7]. ALT solutions
need to be focussed on both improving the aging in place
experience and helping to contain costs for individuals and the
public purse. This paper aims to systematically review cost and
cost-effectiveness studies for ALTs specifically for older people,
and to highlight where research is needed in order to make a case
for ALTs.
Health interventions are increasingly subjected to economic
evaluation that combines information on effectiveness and cost to
consider the cost-effectiveness of their implementation. There is a
growing body of research evidence describing the effectiveness and
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acceptability of ALTs [8], and more specifically ALTs for older
people [5,9]. There has however not been a review covering the
economic/cost analyses for the use of ALTs that could facilitate
aging in place amongst older people, leaving an important gap in
the research that this review specifically aims to address. A specific
example of this gap is illustrated by the findings from a recent
Scottish ‘smart technology’ study [10]. This report stated that the
ALTs for older people used in their study could be accepted by
users and staff. The ALTs were effective in reducing the use of
certain health care resources; however the cost of the intervention
was not considered so an economic analysis could not be
performed [10]. Even if the effectiveness of ALTs for older people
is proven to be universally accepted, as with any new health
technology, it is important that the costs and benefits of
widespread adoption are measured so decision makers in
publically and privately funded healthcare systems can make
evidence based decisions [11]. The lack of such research was
evident in a recent overview [12] of systematic reviews that
highlighted several important gaps in the telecare literature, one
being economic analysis.
Methods
Search strategy
A search was undertaken in the two major health economic
evaluation databases: NHS Economic Evaluation Database (NHS
EED) and The Health Economic Evaluations Database (HEED) in
July of 2012; details of the search strategy can be found in Text S1.
NHS EED includes structured abstracts of quality-assessed full
economic evaluations of health care technologies, with the only
criterion for inclusion being that the study is a full economic
evaluation. Like NHS EED, HEED includes full economic
evaluations, and also includes cost analyses, cost-of-illness studies,
and reviews of applied studies that include economic data. The
search was systematic and reproducible. We used double reviewers
for selected abstracts, with a third reviewer to settle any
disagreements.
Assisted living technologies for older people, is a topic without a
clearly defined taxonomy; therefore the extant literature is
described by a range of keywords. Potential keywords were
compiled from ‘on-topic’ papers and mesh terms found in scoping
searches conducted between March and May 2012. A list of 91
potential keywords was compiled and each word or phrase was
searched in NHS EED and HEED. For full keyword list, see Text
S1.
Selection criteria
Abstracts were reviewed to identify studies in English, compar-
ing costs (cost-minimization studies) and cost and outcomes (full
economic evaluations), published in peer reviewed journals. The
ALTs were limited to those designed for older people (mean age in
study 65+) that enable them to live independently in their
residential home/age in place. No specific comparators were
excluded.
Exclusion criteria were:
N Studies aimed at younger populations (average age under 65 or
ages not reported).
N Studies not of human participants (theory or modelling
papers).
N Studies based outside of the individuals’ own homes.
N Interventions involving trained in-home professionals.
N Interventions involving home medical treatment, diagnosis and
management were excluded, as were telecare interventions
that ‘only facilitates the exchange of data between patients and
care professionals’ [5] unless they specifically seek to enable
independence.
N Studies not including comparisons of costs and/or outcomes to
qualify as economic evaluations.
Quality assessment
Studies were assessed using the methods recommended by the
Campbell and Cochrane Economic Methods Group [13]. These
include the methods outlined in the Cochrane handbook and
more recent developments [14] [15], including methods to
incorporate an economic perspective into the GRADE evidence
system [16]. Current guidance from the CCEMG on quality
assessment of cost-analyses is to use relevant components from one
of two checklists: Jefferson et al. (1995) and Drummond et al.
(2005) [17] [11]. In this study we opted to use that provided by
Drummond et al. (2005).
Data synthesis
Our intention was to apply specialist quantitative methods,
including meta-analysis, to our results but, due to the poor and
varied methodological quality of the included studies, we were not
able to do so; therefore we employed a narrative synthesis
approach. With the heterogeneity of the included studies the
straightforward juxtaposition method of narrative synthesis, as
recommended by the Cochrane Handbook [18], is the most
appropriate. Therefore, the aim of this review was to find evidence
for, or against, the cost-effectiveness of ALTs for older people to
age in place as synthesized narratively across both cost and
economic analysis studies; and to consider what the key
determinants were of these outcomes across settings, rather than
provide some pooled estimate that might not be applicable to any
setting.
Data Extraction Strategy
For the systematic review, the following six categories of data
(listed below) were selected for extraction. Definition-classification
data were also extracted, due to the fact that the assisted living
technology field is lacking a standardized taxonomy of the
technologies being assessed, as discussed by [8]; those results are
presented in Table S1. For detailed subcategories of the data
extraction strategy see Text S2.
Categories of data
1. Number of studies identified
2. Study identification and key elements
3. Source of cost data
4. Study perspective
5. Main outcomes
6. Data analysis: Critical Assessment of Economic Evaluation
checklist (Table S2)
Search Results
1. Number of studies identified
A total of 1,955 abstracts were identified and were screened for
inclusion. From these studies, 34 were selected for further
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assessment and the full papers obtained and assessed. From there
eight papers met the inclusion criteria for the review (Figure S1).
2. Study identification and key elements
Seven studies were conducted in the USA, with costs reported in
US Dollars [19–25]. The remaining study [26] was conducted in
Canada and reported in Canadian Dollars. The settings varied
between remote rural, rural, and urban locations. The price year is
important as it allows researchers to calculate how applicable the
results could be to current practice. It was only explicitly stated in
one study [22] and not stated in the others; where, at best, the
price year could be estimated by publication/study date though
that is not recommended practice [11].
Five studies were formal economic evaluations [19–23] com-
paring costs and consequences of two or more interventions [11].
Three were cost-minimisation analyses, which only compared
costs as the interventions were assumed to have equal effect [24–
26]. None of these three studies justified this assumption and the
current consensus within the economic evaluation literature is that
the adoption of a cost-minimisation framework is rarely justified
[27].
From the eight studies, one considered only Home and
Environmental Modifications, [19]; six considered Telemedicine
[20–23,25,26] and one study considered both [24]. The taxonomy
and types of ALTs varied across studies see Table S1 for a detailed
description of the ALTs and associated definitions.
3. Source of Cost Data
The cost data on the resource use was derived from National
Patient Care Database at AAC, or Veterans Association records in
4 studies [6,8,10,13], and was primarily costs rather than charges
to a third party payer. Hospital level data was used to estimate
costs in one study [7] and acquisition costs for the technology (with
these costs based upon the retail price where equipment was
donated) in one [9]. The source of cost data was not stated in the
remaining two studies [11,12]. The consequence of this is that it is
not possible to translate the findings of these studies into the
current time period.
4. Study perspective
From the eight papers, two did not specify the perspective of the
study [19,20]. One took the perspective of a public health system
[26]. Two papers took the perspective of a hospital/health care
provider [21,22]. Two took the perspective of the Veterans
Administration in the US [24,25] and one took the perspective of
the direct provider/purchaser [23].
5. Main Outcomes
Study Design. Of the eight identified studies, five were
conducted as part of randomised control trials [19,21–23,25], two
were conducted as part of quasi-experimental studies [20,26]. Of
these two, one did not state the design beyond having control and
intervention groups [20] and the other had no control group
because it stated that having one would be unethical [26]. The
eighth study was a retrospective matched comparative study [24].
Costs studied. All of the studies reported on costs to the
payer of providing the intervention. There was little reporting of
the included costs consequent to the interventions. For example,
downstream costs such as any changes in hospital and emergency
care admission as a result of the intervention.
Changes consequent to the intervention were reported by Mann
et al. (1999) as care aide costs, nurses, case managers, occupational
and physical therapists and speech pathologists, nursing home
stays and hospital costs [19]. Johnston et al. (2000) included costs
of pharmacy services, laboratory, physician visits, Emergency
Department (ED) visits, and inpatient treatment as well as the
direct costs of home healthcare [20]. Noel & Vogel (2000)
accounted for home visits, hospitalisations and ED visits [21].
Costs for clinic visits, hospitalisation, and transport were reported
by Noel & Vogel (2004) [22]. Vincent et al. (2006) included
hospital stays and home care services [26]. Finkelstein et al. (2006)
inferred that there was a reduction in downstream direct cost
evidenced by the documentation of fewer discharges to higher
levels of care within the two intervention groups [23]. Bendixen et
al. (2009) only reported future health care costs [24] and Wray et
al. (2010) included outpatient, inpatient, and nursing home need
[25]. None of the studies reported on indirect costs i.e.
productivity losses borne by society due to health issues.
Patient characteristics. All studies had a mean patient and/
or carer population age of above 65 in both intervention and
control groups. Of the included studies, the overall mean
population age was 72 years. Ages ranged from an intervention
group mean of 68 years [21] to a mean of 81 years [26].
The split between male and female study participants varied
between studies. Three studies had a higher percentage of women
than men with 70% women [19], 59% [20], and 71% [26]. Two
studies had a higher percentage of men with 95% [21], and 97%
[22]. One study had an approximately even number of men and
women [23] and two studies did not state the difference, both of
which were working with US armed forces veterans [24,25].
Four studies had a patient population comprised of newly
diagnosed patients with a wide range of complex co-morbidities
[20] [21] [22] [23]. One study considered interventions for home-
based frail older people [19]. Another study looked at a patient
population of veterans living at home with complex co-morbidities
[24] and dementia [25]. In a further two studies, the focus was on
‘live-in’ caregivers, with one focusing on a close relative (as the
caregiver) of veterans living at home with moderate to severe
dementia [25] and the other targeting a close relative (as the
caregiver) who lived with an older person who has a co-morbidity/
barrier to independent living [26].
Primary outcomes of studies. Four of the studies reported
effects on one or more outcomes [19,20,22,24]. Mann (1999)
reported on the effectiveness of assistive technologies and home
environmental interventions using a variety of measures of
functional independence as well as pain [19]. Johnston et al.
(2000) reported on costs in a cost-effectiveness study of supportive
care [20]. Noel et al (2004) used three quality indicators as
outcomes (medication compliance, knowledge of disease, and
ability for self-care), as well as reporting the degree of patient
satisfaction [22]. Lastly, Bendixen et al. (2009) measured serum
glucose, cognitive status, functional level, patient satisfaction with
care and self-rated health status and quality of life [24]. Although
used in a non comparative way, Vincent et al. (2006) used the SF-
12 [28] to capture quality of life in the cohort in their cost analysis
(as well as a measure of care giver burden) allowing for the possibly
of maximizing gain across different technologies and sectors
(allocative efficiency) [26]; the rest of the studies reported
intervention-specific measures, with the aim of achieving increases
in specific outcomes using the fewest resources (technical
efficiency).
6. Data analysis: Critical Assessment of Economic
Evaluation checklist
To determine if the evaluations were of acceptable quality, they
were all assessed according to a well-recognized economic
evaluation checklist [11]. The checklist (Table S2) was adapted
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from the Drummond et al. (2005) checklist and was used to
illustrate the assessment of the validity of results found in this
review. It is not expected that every economic evaluation satisfy all
checklist criteria, though the systematic application of these
questions can assist in the identification of strengths and
weaknesses amongst the papers in this review. Table S2 illustrates
the result of the systematic critical assessment of the data,
demonstrating which studies present a sound economic evaluation.
According to the assessment methods recommended by the
Campbell and Cochrane Economic Methods Group, all the
studies were judged to have low methodological quality [11].
The methodological quality of the studies is a reflection of the
heterogeneous data on costs and outcomes reported across studies.
Nevertheless, five studies reported that the intervention had lower
costs (at least in the short-term) than the comparator group
[19,21–23,25]. One study, where measures were taken before and
after the introduction of telesurveillance, reported the intervention
to have lowered healthcare expenditure in the intervention group,
though there was no control group due to ethical reasons [26].
Another study found that there was no difference in costs between
the intervention group and comparator, although after the
intervention there were increases in clinic visits but decreases in
hospital and nursing home stays for the intervention group [24].
One study found that the total mean costs of care were lower than
in the control once the costs of home-healthcare were excluded
[20].
Three studies reported non-monetary benefits [19,20,22]. The
first found functional independence and mobility declined for both
intervention and control group, but considerably more in the
control; and that pain increased significantly less for the
intervention than the control but physical independence, mobility
occupation, and social integration were unchanged [19]. The
second reported an association with improved medication
compliance, knowledge of disease, and increased patient satisfac-
tion [20]. The third found no significant effects on cognitive status,
functional level, satisfaction with care or self-rated health status
[22]. One study measured functional decline in terms of
emergency and non-emergency care and found ALTs associated
with reductions in hospital and nursing home stays [24]. No study
included a preference based outcome measure meaning that there
was no consideration of the value users of the ALTs place on the
reported outcomes.
Discussion
There is a potential for growth in the market for ALTs,
although the growth of this market may not have developed as
quickly as expected [29]. One reason for this may be the lack of
studies proving the economic viability of ALTs [30–32]. Clearly
there is a need for further economic evaluation of the ALTs that
enable aging in place for older people [12]. This systematic review
highlights a number of important issues. Firstly, more high quality
studies investigating the cost-effectiveness of ALTs are required
The results of the Whole System Demonstrator programme in the
United Kingdom may help in this process, although there is still a
lack of rigorous cost-effective work [5]. Cost-effectiveness studies
can be an important source of information for public and private
providers and more studies could help to stimulate the ALT
market. A possible reason why there have been few cost-
effectiveness studies of ALTs may be because new technology is
consistently developing and as technologies ‘age’ the costs can
change.
Secondly, an increased focus on defining and measuring the
benefits of ALTs is required. Outcome measurement is not
well-developed in social care and the aging process. There is
important research on-going but it has yet to make it into the
wider evaluation of ALT literature. The included studies lacked a
consistent use of a health related quality of life measures as an
outcome; using such measures would allow issues concerning
allocative efficiency to be considered, whereas the outcomes
measured in this review were better placed to answer questions
about technical efficiency. Focusing solely on monetary change as
an outcome is problematic as it is possible for an intervention to
have an ‘economic benefit’ but the health and wellbeing of
participants may not necessarily improve.
Furthermore, health related quality of life should not be limited
to just physical aspects of well-being but extended to the mental
wellbeing of participants as well. With ALTs allowing older people
to age in place, the change in mental outlook should be measured
as an outcome in future economic evaluations. The capabilities
approach would seem to be an exciting opportunity, as it focuses
on self-reported wellbeing in older people as defined in a broader
sense instead of exclusively on health [33]. The ICECAP-O
(ICEpop CAPability measure for Older people) is one example of
this approach as it contains subjective measures including a
dimension solely about independence [34]. This instrument has
recently been used as the measure for a secondary outcome in a
UK based study involving older people, though the tool is still new
and research regarding its validation is ongoing [35]. Utilizing a
preference-based instrument provides decision makers with
additional information that includes valuations of the states the
tools measure. Two studies in this review [24,26] actually collected
data that could have been used to perform an economic evaluation
and so demonstrate whether the interventions were cost effective
but no such results were presented. Measures like the ICECAP-O
may be able to better capture changes in the overall wellbeing of
older people using ALTs to age in place specifically, rather than
solely focusing on function or health related quality of life (e.g.
EQ-5D) [36]. Such tools are promising and although research is
on-going, more is needed [36].
Thirdly, there is a need to consider where benefits accrue, and
so which perspective should be taken. Many ALTs produce
benefits that accrue to individuals, or groups, involved in the care
needs of the user, such as: household members, wider family and
carers, as well as the state, in the form of local and national
funders. This presents a challenge for research and suggests that
the best approach to evaluation may be cost-benefit analysis,
where wider notion of costs and benefits can be valued.
Finally, there is a need for a clear taxonomy describing ALTs.
ALTs encompass a broad range of devices: from basic home
adaptations to help frail older people obtain control over their
environment, to advances in telecare and the cutting edge
technology found in ‘‘smart homes’. With such diversity, there is
uncertainty within the literature as to the categorization and
terminology of technologies [7]. Studies and reviews have called
for more research and work on these issues [8]. We concur that
more clarity regarding taxonomy and the outcomes of ALTs is
required. Additionally, research on ALTs specifically facilitating
aging in place for older people could benefit from developments in
taxonomy so the issues can be analysed separately from telecare in
the management of chronic conditions.
Conclusion
The strengths of our study are that the search was systematic
and reproducible. The identified studies were quality assessed
according to the criteria proposed by the Campbell and Cochrane
Economic Methods Group [17]; which deemed the methodolog-
Systematic Review of Assisted Living Technologies
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ical quality to be weak across studies. The inclusion criterion was
strict as we wanted to target only ALTs that assist with aging in
place opposed to telecare in the management of chronic
conditions; though as a result there may be related studies (i.e.
modelling papers) that were excluded. The search was limited to
full text articles available in the English language, though both
HEED and NHS EED do not limit their searches to the English
language and provide the structured abstracts are written in
English. All of the studies were based in North American settings
which may not be universally applicable to other international
settings. Two of the studies had the United States Department of
Veterans Affairs as its perspective which is publicly funded though
neither study took into account the cost of the intervention in its
analysis.
The review has highlighted some key areas of research for
ALTs, social care and aging in place. ALTs may be an innovative
solution to the problems posed by aging populations, but more
research concerning their cost-effectiveness is required.
Supporting Information
Figure S1 Review and Selection of Articles. This figure
shows the stages of the systematic review selection process as
detailed with the number of studies progressing through the
inclusion and exclusion criteria.
(DOCX)
Table S1 ALT Definition Classification. This table displays
the results of the varying taxonomy across the included studies as
categorized by how each ALT was titled and the specific details of
what the technology was in each study. The two main categories
are ‘Home Modifications (Table A)’ and ‘Remote Patient-Health
Professional Communication’ (Table B).
(DOCX)
Table S2 Critical Assessment of Economic Evaluation
checklist. This checklist was adapted from the Drummond et al.
(2005) checklist and was used to illustrate the assessment of the
validity of results found in this review, demonstrating which studies
present a sound economic evaluation.
(DOCX)
Checklist S1 PRISMA 2009 Checklist. PRISMA stands for
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses and is an evidence-based minimum set of items for
reporting in systematic reviews and meta-analyses. Checklist S1
shows how the authors have completed the 27-item PRISMA
2009 checklist to accompany the PRISMA 2009 flow diagram
(Flow Diagram S1).
(DOCX)
Flow Diagram S1 PRISMA 2009 Flow Diagram. PRISMA
stands for Preferred Reporting Items for Systematic Reviews and
Meta-Analyses and is an evidence-based minimum set of items for
reporting in systematic reviews and meta-analyses. Flow Diagram
S1 is the PRISMA 2009 four-phase flow diagram of the systematic
review process to accompany the PRISMA 2009 Checklist
(Checklist S1).
(DOCX)
Text S1 Keywords & Search Strings used for Systematic
Search. This document lists the keywords and database search
strategy used for the systematic search.
(DOCX)
Text S2 Data Extraction Strategy. This document presents
the full outline of the data extracted from the included studies.
(DOCX)
Acknowledgments
A special thanks to Professor Luke Vale and the referees for their
comments.
Author Contributions
Conceived and designed the experiments: EG PM JW. Performed the
experiments: EG. Analyzed the data: EG PM. Wrote the paper: EG PM
JW.
References
1. Gitlin LN (2003) Conducting Research on Home Environments: Lessons
Learned and New Directions. The Gerontologist 43: 628–637.
2. Wiles JL, Leibing A, Guberman N, Reeve J, Allen RES (2011) The Meaning of
‘‘Ageing in Place’’ to Older People. The Gerontologist.
3. Beer JM, Smarr C, Chen TL, Prakash A, Mitzner TL, et al. (2012) The dome-
4. World Health Organization (2014) Definition of an older or elderly person.
Proposed Working Definition of an Older Person in Africa for the MDS Project.
5. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, et al. (2012) Effect of
telehealth on use of secondary care and mortality: findings from the Whole
System Demonstrator cluster randomised trial. British Medical Journal 344.
6. Sood S, Mbarika V, Jugoo S, Dookhy R, Doarn CR, et al. (2007) What is
telemedicine? A collection of 104 peer-reviewed perspectives and theoretical
underpinnings. Telemedicine Journal and E-Health 13: 573–590.
7. Halford S, Lotherington AT, Obstfelder A, Dyb K (2010) GETTING THE
WHOLE PICTURE? New information and communication technologies in
healthcare work and organization. Information Communication & Society 13:
442–465.
8. Martin S, Kelly G, Kernohan G, McCreight B, Nugent C (2008) Smart home
technologies for health and social care support. Cochrane Database of
Systematic Reviews 2008. The Cochrane Library: John Wiley & Sons.
9. Barlow J, Singh D, Bayer S, Curry R (2007) A systematic review of the benefits
of home telecare for frail elderly people and those with long-term conditions.
Journal of Telemedicine and Telecare 13: 172–179.
10. Bowes A, McColgan G (2006) Smart technology and community care for older
people: innovation in West Lothian, Scotland. Age Concern Scotland.
11. Drummond MF, Stoddart GL, Torrance GW (2005) Methods for the Economic
Evaluation of Health Care Programmes; Publications OM, editor.
12. Bahaadinbeigy K, Yogesan K, Wootton R (2010) Gaps in the systematic reviews
of the telemedicine field. Journal of Telemedicine and Telecare 16: 414–416.
13. Shemilt I, Byford S, Drummond M, Eisenstein E, Knapp M, et al. (2008)
Incorporating Economics Evidence. In Higgins J, Green S (eds) Cochrane
Handbook for Systematic Reviews of Interventions. Chichester: Hohn Wiley &
Sons.
14. Shemilt I, McDaid D, Marsh K, Henderson C, Bertranou E, et al. (2013) Issues
in the incorporation of economic perspectives and evidence into Cochrane
reviews. Systematic reviews 2.
15. Shemilt I, Mugford M, Donaldson C, Vale L, Marsh K (2010) Evidence-based
decisions and economics: lessons for practice. Evidence based economics.
London: Wiley Books.
16. Brunetti M, Shemilt I, Pregno S, Vale L, Oxman AD, et al. (2013) GRADE
guidelines: 10. Considering resource use and rating the quality of economic
evidence. Journal of Clinical Epidemiology 66: 140–150.
17. Jefferson T, Demicheli V, Entwistle V (1995) ASSESSING QUALITY OF
ECONOMIC SUBMISSIONS TO THE BMJ. British Medical Journal 311:
393–394.
18. Higgins JPT, (editors) GS (2009) Cochrane Handbook for Systematic Reviews of
Interventions Version 5.0.2 [updated September 2009]. The Cochrane
Collaboration.
19. Mann WC, Ottenbacher KJ, Fraas L, Tomita M, Granger CV (1999)
Effectiveness of assistive technology and environmental interventions in
maintaining independence and reducing home care costs for the frail elderly -
A randomized controlled trial. Archives of Family Medicine 8: 210–217.
20. Johnston B, Wheeler L, Deuser J, Sousa KH (2000) Outcomes of the Kaiser
Permanente tele-home health research project. Archives of Family Medicine 9:
40–45.
21. Noel HC, Vogel DC (2000) Resource costs and quality of life outcomes for
homebound elderly using telemedicine integrated with nurse case management.
Care Management 6(5): 22–24, 26–82, 30–31.
22. Noel HC, Vogel DC, Erdos JJ, Cornwall D, Levin F (2004) Home telehealth
reduces Healthcare costs. Telemedicine Journal and E-Health 10: 170–183.
Systematic Review of Assisted Living Technologies
PLOS ONE | www.plosone.org 5 July 2014 | Volume 9 | Issue 7 | e102705
2012 5 8  March 2012. pp. 335–342.–
sticated robot: Design guidelines for assisting older adults to age in place;
23. Finkelstein SM, Speedie SM, Potthoff S (2006) Home telehealth improves
clinical outcomes at lower cost for home healthcare. Telemedicine Journal and
E-Health 12: 128–136.
24. Bendixen RM, Levy CE, Olive ES, Kobb RF, Mann WC (2009) Cost
Effectiveness of a Telerehabilitation Program to Support Chronically Ill and
Disabled Elders in Their Homes. Telemedicine Journal and E-Health 15: 31–38.
25. Wray LO, Shulan MD, Toseland RW, Freeman KE, Vasquez BE, et al. (2010)
The Effect of Telephone Support Groups on Costs of Care for Veterans With
Dementia. Gerontologist 50: 623–631.
26. Vincent C, Reinharz D, Deaudelin I, Garceau M, Talbot LR (2006) Public
telesurveillance service for frail elderly living at home, outcomes and cost
evolution: a quasi experimental design with two follow-ups. Health and Quality
of Life Outcomes 4.
27. Briggs AH, O’Brien BJ (2001) The death of cost-minimization analysis? Health
Economics 10(2): 179–184.
28. Burdine JN, Felix MRJ, Abel AL, Wiltraut CJ, Musselman YJ (2000) The SF-12
as a population health measure: An exploratory examination of potential for
application. Health Services Research 35: 885–904.
29. Lushai G, Cox T (2012) Assisted Living Technology, a market and technology
review. University of the West of England.
30. Aanesen M, Lotherington AT, Olsen F (2011) Smarter elder care? A cost-
effectiveness analysis of implementing technology in elder care. Health
Informatics Journal 17: 161–172.
31. Vimarlund V, Olve N-G (2005) Economic analyses for ICT in elderly
healthcare: questions and challenges. Health Informatics Journal 11: 309–321.
32. Whitten PS, Mair FS, Haycox A, May CR, Williams TL, et al. (2002) Systematic
review of cost effectiveness studies of telemedicine interventions. BMJ 324:
1434–1437.
33. Grewal I, Lewis J, Flynn T, Brown J, Bond J, et al. (2006) Developing attributes
for a generic quality of life measure for older people: Preferences or capabilities?
Social Science & Medicine 62: 1891–1901.
34. Coast J, Flynn TN, Natarajan L, Sproston K, Lewis J, et al. (2008) Valuing the
ICECAP capability index for older people. Social Science & Medicine 67: 874–
882.
35. Henderson C, Knapp M, Ferna´ndez J, Beecham J, Hirani SP, et al. (2013) Cost
effectiveness of telehealth for patients with long term conditions (Whole Systems
Demonstrator telehealth questionnaire study): nested economic evaluation in a
pragmatic, cluster randomised controlled trial. BMJ 346.
36. Davis JC, Bryan S, McLeod R, Rogers J, Khan K, et al. (2012) Exploration of
the association between quality of life, assessed by the EQ-5D and ICECAP-O,
and falls risk, cognitive function and daily function, in older adults with mobility
impairments. Bmc Geriatrics 12.
Systematic Review of Assisted Living Technologies
PLOS ONE | www.plosone.org 6 July 2014 | Volume 9 | Issue 7 | e102705
